COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: insights from a narrative literature review

N Mahroum, N Lavine, A Ohayon, R Seida… - Frontiers in …, 2022 - frontiersin.org
Despite their proven efficacy and huge contribution to the health of humankind, vaccines
continue to be a source of concern for some individuals around the world. Vaccinations …

Efficacy and safety of COVID‐19 vaccines

Cochrane Emergency and Critical Care … - Cochrane Database …, 1996 - cochranelibrary.com
Background Different forms of vaccines have been developed to prevent the SARS‐CoV‐2
virus and subsequent COVID‐19 disease. Several are in widespread use globally …

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

X Zhu, KA Gebo, AG Abraham, F Habtehyimer… - The Lancet …, 2023 - thelancet.com
Background Cytokines and chemokines play a critical role in the response to infection and
vaccination. We aimed to assess the longitudinal association of COVID-19 vaccination with …

Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination

EE Ooi, A Dhar, R Petruschke, C Locht, P Buchy… - npj Vaccines, 2022 - nature.com
COVID-19 vaccines are effective and important to control the ongoing pandemic, but vaccine
reactogenicity may contribute to poor uptake. Analgesics or antipyretic medications are often …

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines

AK Hvidt, EAM Baerends, OS Søgaard… - Frontiers in …, 2022 - frontiersin.org
The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …

[HTML][HTML] Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?

CS Benn, F Schaltz-Buchholzer, S Nielsen, MG Netea… - Iscience, 2023 - cell.com
We examined the possible non-specific effects of novel mRNA-and adenovirus-vector
COVID-19 vaccines by reviewing the randomized control trials (RCTs) of mRNA and …

COVID-19, vaccines, and thrombotic events: a narrative review

MG Abrignani, A Murrone, L De Luca, L Roncon… - Journal of clinical …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

SARS-CoV-2 Spike Proteins and Cell–Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung …

B Bhargavan, GD Kanmogne - International journal of molecular sciences, 2023 - mdpi.com
COVID-19 progression often involves severe lung injury, inflammation, coagulopathy, and
leukocyte infiltration into pulmonary tissues. The pathogenesis of these complications is …

Ocular vascular events following COVID-19 vaccines: a systematic review

H Abu Serhan, A Abdelaal, MT Abuawwad, MJJ Taha… - Vaccines, 2022 - mdpi.com
The main aim of this study is to investigate the current evidence regarding the association
between COVID-19 vaccination and ocular vascular events. The protocol is registered on …

Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?

R Roytenberg, A García-Sastre, W Li - Frontiers in medicine, 2023 - frontiersin.org
Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …